Implementation faced the expected challenges. Outcomes from July 2005 through June 2008 will be presented. Preliminary outcomes from 12 sites and 2425 patients (7-2005 through 12-2007) suggest no significant differences between sites in Large Metropolitan Areas and Rural Incorporated Cities in: number of patients seen, reached for follow-up, and percentage of patients quit at 6-months post-discharge. The quit rates in suburban areas were lower than their rural and urban counterparts (p < 0.05). This was partially due to “tobacco interventionist” turnover at the sites in this classification.
6-Month Post-Discharge Follow-up Results
Of 507 patients eligible for follow-up in LMAs, 348 were contacted and 126 of those had quit. Percentage of patients quit: 24.85% ITT; 36.21% CNT. In SMAs, of 735 patients eligible, 458 were contacted and 113 had quit. Percentage of patients quit: 15.37% ITT; 24.62% CNT. In RICs, 679 patients were eligible, 412 were contacted and 134 had quit. Percentage of patients quit: 19.74% ITT, 35.52% CNT.
Satisfaction with treatment and usefulness of the treatment were also similar.
These results and others show that intensive, face-to-face, evidence-based treatment for tobacco dependence can be as effectively delivered in rural areas as in metropolitan areas as long as adequate systems exist to support the sites, the clinicians, and evaluation. Given the higher prevalence of tobacco use in rural areas, providing access to intensive cessation options is an important element of any tobacco control program.
*ITT=Intent to Treat. CNT=all patients contacted.
Learning Objectives:
1. Describe evidence-based treatment for tobacco dependence.
2. Discuss barriers involved with delivering tobacco treatment in rural settings.
3. Discuss methods for addressing barriers to delivering tobacco treatment in rural settings.
Keywords: Rural Health Care, Tobacco
Qualified on the content I am responsible for because: I currently serve as director of Arkansas Statewide Tobacco Programs and Services and am responsible for service delivery, data collection, data managagement and evaluation for the programs.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
![[ Visit Client Website ]](images/banner.gif)